Alcinous Pharmaceuticals is a biotechnology and pharmaceutical company, established in 2016 by three PhD students at the University of Rhode Island. The company is focused on creating therapeutics for aggressive cancers through a novel drug discovery pipeline. Their approach involves leveraging an innovative team to develop new classes of therapeutics.
In May 2020, the company secured a $600.00K investment in a Seed Round from Slater Technology Fund. With its headquarters in the United States, Alcinous Pharmaceuticals is poised to make significant strides in the field of cancer therapeutics.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | $600.00K | 1 |
|
12 May 2020 |
No recent news or press coverage available for Alcinous Pharmaceuticals.
We care about your data, and we'd love to use cookies make your experience better.
